- PureTech Health said affiliate Vedanta Biosciences had announced an $18.5m extension of a financing round, bringing the total for the round to $45.5m.

The new investment came from JSR Corporation, Shumway Capital, SymBiosis and Partners Investment.

They joined previously announced participants of the round, including the Bill & Melinda Gates Foundation and Bristol-Myers Squibb.

Proceeds from the financing would be used to advance Vedanta's broad clinical portfolio in indications including food allergy, advanced or metastatic cancers, and infection.

Story provided by